Skip to main content
. 2014 Sep;58(9):5047–5053. doi: 10.1128/AAC.02830-14

TABLE 4.

Summary of PK dataa

MAb Cohort Tmax (day) Cmax (μg/ml) AUCinf (μg/day/ml) t1/2 (days) Vzb (ml/kg) CLc (ml/day/kg)
Aa A 0.05 (0.046, 0.079) 0.23 (0.23, 0.24) 2.08 (2.04, 2.1) 8.9 (8.8, 10.1) 69 (67, 77) 5.3 (5.3, 5.5)
B 0.09 (0.084, 0.148) 1.2 (1.1, 1.23) 11.63 (9.91, 16.3) 12.4 (10, 14.1) 92 (72, 97) 4.7 (3.4, 5.6)
C 0.085 (0.083, 0.094) 2.35 (2.27, 2.88) 22.09 (20.4, 30.06) 12.3 (11.3, 13.7) 88 (82, 93) 4.9 (3.7, 5.4)
Ab A 0.046 (0.046, 0.077) 0.2 (0.19, 0.21) 0.66 (0.62, 0.79) 2.5 (2.3, 2.8) 59 (56, 65) 16.6 (14.1, 17.6)
B 0.129 (0.057, 0.17) 1.16 (1.13, 1.24) 9.42 (6.86, 12.97) 12.8 (7.8, 14) 85 (81, 105) 5.9 (4.3, 8.2)
C 0.085 (0.083, 0.094) 2.62 (2.07, 2.93) 18.64 (14.43, 21.44) 10.3 (8.6, 11.3) 95 (88, 99) 6 (5, 7.7)
Ac A 0.11 (0.048, 0.167) 0.23 (0.22, 0.24) 2.9 (2.48, 3.25) 15.5 (12.1, 21.2) 87 (79, 112) 3.8 (3.4, 4.4)
B 0.085 (0.055, 0.091) 1.19 (1.07, 1.3) 18.64 (16.01, 23.13) 26.9 (23.7, 32.1) 110 (83, 128) 3 (2.4, 3.5)
C 0.085 (0.083, 0.144) 2.4 (2.32, 2.84) 35.08 (33.33, 41.4) 24.4 (23.2, 25.5) 105 (96, 110) 3.1 (2.8, 3.3)
a

All data are median (interquartile range).

b

Vz, apparent volume of distribution during terminal phase.

c

CL, clearance.